NO163859C - Fremgangsmaate ved fremstilling av terapeutisk aktive succinylerte jernholdige proteiner. - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk aktive succinylerte jernholdige proteiner.

Info

Publication number
NO163859C
NO163859C NO830707A NO830707A NO163859C NO 163859 C NO163859 C NO 163859C NO 830707 A NO830707 A NO 830707A NO 830707 A NO830707 A NO 830707A NO 163859 C NO163859 C NO 163859C
Authority
NO
Norway
Prior art keywords
succinylated
sustainable
proteins
procedure
preparation
Prior art date
Application number
NO830707A
Other languages
English (en)
Norwegian (no)
Other versions
NO163859B (no
NO830707L (no
Inventor
Giancarlo Sportoletti
Pier Giuseppe Pagella
Pietro Cremonesi
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of NO830707L publication Critical patent/NO830707L/no
Publication of NO163859B publication Critical patent/NO163859B/no
Publication of NO163859C publication Critical patent/NO163859C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/77—Ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO830707A 1982-03-02 1983-03-01 Fremgangsmaate ved fremstilling av terapeutisk aktive succinylerte jernholdige proteiner. NO163859C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19908/82A IT1150213B (it) 1982-03-02 1982-03-02 Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche

Publications (3)

Publication Number Publication Date
NO830707L NO830707L (no) 1983-09-05
NO163859B NO163859B (no) 1990-04-23
NO163859C true NO163859C (no) 1990-08-01

Family

ID=11162241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830707A NO163859C (no) 1982-03-02 1983-03-01 Fremgangsmaate ved fremstilling av terapeutisk aktive succinylerte jernholdige proteiner.

Country Status (30)

Country Link
US (1) US4493829A (pt)
JP (1) JPS58159421A (pt)
KR (1) KR860001571B1 (pt)
AR (1) AR229805A1 (pt)
AT (1) AT390067B (pt)
AU (1) AU548034B2 (pt)
BE (1) BE896051A (pt)
BR (1) BR8301005A (pt)
CA (1) CA1222508A (pt)
CH (1) CH653893A5 (pt)
DE (1) DE3306622A1 (pt)
DK (1) DK159824C (pt)
ES (1) ES8403493A1 (pt)
FI (1) FI77574C (pt)
FR (1) FR2522664B1 (pt)
GB (1) GB2115821B (pt)
GR (1) GR78470B (pt)
HK (1) HK56086A (pt)
IE (1) IE54572B1 (pt)
IN (1) IN156079B (pt)
IT (1) IT1150213B (pt)
LU (1) LU84672A1 (pt)
MX (1) MX9203631A (pt)
MY (1) MY8600588A (pt)
NL (1) NL190399C (pt)
NO (1) NO163859C (pt)
PH (1) PH18538A (pt)
PT (1) PT76318B (pt)
SE (1) SE462716B (pt)
ZA (1) ZA831350B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1186787B (it) * 1985-11-06 1987-12-16 Mediolanum Farmaceutici Srl Ferro-derivati della globina e dell'acetilglobina dotati di elevata biodisponibilita',processo di preparazione e composizioni farmaceutiche
IT1207996B (it) * 1986-03-18 1989-06-01 Magis Farmaceutici Composti contenenti ferro biodisponibile, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
IT1222912B (it) * 1987-10-14 1990-09-12 Italfarmaco Spa Derivati polipeptidici a elevato tenore di ferro e altamente solubili atti alla terapia marziale procedimenti di preparazione e loro forme farmaceutiche
IT1223122B (it) * 1987-11-13 1990-09-12 Unibios Spa Derivati proteici del ferro altamente biodisponibile e tollerabili, loro preparazione e composizioni farmaceutiche che li contengono
US5322678A (en) * 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
IT1237783B (it) * 1989-11-16 1993-06-17 Italfarmaco Spa Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
IT1251702B (it) * 1991-10-16 1995-05-19 Mediolanum Farmaceutici Srl Complessi del ferro con la conalbumina e i suoi derivati
IT1251725B (it) * 1991-11-04 1995-05-23 Italfarmaco Spa Composti di ferro biodisponibile con ovotransferrina acilata o suoi derivati di idrolisi acilati
IT1291289B1 (it) * 1997-04-30 1999-01-07 Derivati Organici Lab Complessi costituiti da fe(iii) un composto poliidrossilato e ovalbumina
ITMO20040200A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Processo per la produzione di complessi ferro succinilcaseina e ferro casein acetil aspartilato e loro utilizzato nelle relative composizioni farmaceutiche.
RU2408601C2 (ru) * 2005-12-06 2011-01-10 Вифор (Интернациональ) Аг Способ получения железосодержащего сукцинилированного казеина
US8795724B2 (en) * 2008-06-12 2014-08-05 Universite Laval Modified protein excipient for delayed-release tablet
MX346317B (es) 2010-06-30 2017-03-15 Italfarmaco Spa Succinilato de caseina de hierro (iii) y metodo para la preparacion del mismo.
CN102838667B (zh) * 2012-09-25 2014-06-25 济川药业集团有限公司 一种蛋白琥珀酸铁的制备方法
AU2015204192B2 (en) * 2014-01-06 2020-03-26 Shield TX (UK) Limited Dosage regimen of ferric trimaltol
GB201416293D0 (en) 2014-09-15 2014-10-29 Solvotrin Therapeutics Ltd Methods and preparations
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
EP3034512B1 (en) 2014-12-19 2017-12-06 Ioulia Tseti A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions
EA201892065A1 (ru) 2016-03-15 2019-04-30 Солвотрин Терапьютикс Лтд Композиции и способы для увеличения поглощения железа в организме млекопитающего

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932589A (en) * 1956-03-12 1960-04-12 Glidden Co Paper coating compositions and process
IL26551A (en) * 1965-10-08 1970-06-17 Diagnostic Data Inc Injectable protein and method of isolation and use
US3756682A (en) * 1967-02-13 1973-09-04 Schlumberger Technology Corp Method for outgassing permanent magnets
US3873296A (en) * 1968-06-24 1975-03-25 Ashmead H H Increasing metals in biological tissue
GB1284409A (en) * 1968-12-31 1972-08-09 Unilever Ltd Oil emulsions containing acylated protein emulsifiers
US3764711A (en) * 1971-03-29 1973-10-09 Carnation Co Acylated protein for coffee whitener formulations
US4017605A (en) * 1974-09-20 1977-04-12 Diagnostic Data, Inc. Acylated orgotein
US4020158A (en) * 1975-08-08 1977-04-26 Ashmead H H Increasing metals in biological tissue
NZ183858A (en) * 1976-12-17 1979-10-25 Ashmead Hh Polyvalent metal proteinates as food additives
US4208405A (en) * 1977-01-24 1980-06-17 Kelatron Pharmaceutical Division of Intermountain Laboratories Inc. Trace element composition for iron deficiency anemia
US4172072A (en) * 1977-10-20 1979-10-23 Ashmead H H Buffered enzymatically produced metal proteinates
US4216144A (en) * 1977-10-20 1980-08-05 Ashmead H H Soluble iron proteinates
SE451539B (sv) * 1979-11-16 1987-10-19 Sik Svenska Livsmedelsinst Hemjernanrikat aminosyrapreparat framstellt av hemproteiner och forfarande for dess framstellning

Also Published As

Publication number Publication date
SE8301129L (sv) 1983-09-03
DE3306622C2 (pt) 1990-02-22
KR840003648A (ko) 1984-09-15
GB2115821A (en) 1983-09-14
US4493829A (en) 1985-01-15
IE830428L (en) 1983-09-02
DK84883A (da) 1983-09-03
ES519944A0 (es) 1984-04-01
NL190399B (nl) 1993-09-16
PH18538A (en) 1985-08-09
DE3306622A1 (de) 1983-09-15
IN156079B (pt) 1985-05-11
NO163859B (no) 1990-04-23
PT76318B (en) 1986-02-12
LU84672A1 (fr) 1983-09-08
GB8305691D0 (en) 1983-04-07
FR2522664B1 (fr) 1986-08-14
DK84883D0 (da) 1983-02-24
AT390067B (de) 1990-03-12
BR8301005A (pt) 1983-11-22
KR860001571B1 (ko) 1986-10-08
FI830678L (fi) 1983-09-03
AR229805A1 (es) 1983-11-30
IT8219908A0 (it) 1982-03-02
FI830678A0 (fi) 1983-03-01
IT1150213B (it) 1986-12-10
DK159824C (da) 1991-04-29
CA1222508A (en) 1987-06-02
MX9203631A (es) 1992-07-01
IE54572B1 (en) 1989-11-22
MY8600588A (en) 1986-12-31
ATA70983A (de) 1989-08-15
CH653893A5 (it) 1986-01-31
ZA831350B (en) 1983-11-30
FR2522664A1 (fr) 1983-09-09
HK56086A (en) 1986-08-01
FI77574C (fi) 1989-04-10
DK159824B (da) 1990-12-10
FI77574B (fi) 1988-12-30
GR78470B (pt) 1984-09-27
JPH0470317B2 (pt) 1992-11-10
AU1185883A (en) 1983-09-08
SE8301129D0 (sv) 1983-03-01
PT76318A (en) 1983-04-01
NO830707L (no) 1983-09-05
NL8300757A (nl) 1983-10-03
GB2115821B (en) 1985-07-17
BE896051A (nl) 1983-07-01
SE462716B (sv) 1990-08-20
ES8403493A1 (es) 1984-04-01
AU548034B2 (en) 1985-11-21
NL190399C (nl) 1994-02-16
JPS58159421A (ja) 1983-09-21

Similar Documents

Publication Publication Date Title
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO851400L (no) Fremgangsmaate ved fremstilling av fysiologisk aktive polypeptider.
NO163859C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive succinylerte jernholdige proteiner.
NO884154L (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO154905C (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO157735C (no) Fremgangsmaate for fremstilling av alfa-arylalkansyrer.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO882856L (no) Fremgangsmaate for fremstilling av immunoundertrykkende peptider.
NO893794D0 (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
NO154635C (no) Fremgangsmaate for fremstilling av terapeutisk aktive ergotalkaloider.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.